PURPOSE/ OBJECTIVES: To determine the predictors of participation in a smoking-cessation program among patients with head and neck cancer. DESIGN: This cross-sectional study is a substudy of a larger, randomized trial of patients with head and neck cancer that determined the predictors of smokers' participation in a cessation intervention. SETTING: Otolaryngology clinics at three Veterans Affairs medical centers (Ann Arbor, MI, Gainesville, FL, and Dallas, TX), and the University of Michigan Hospital in Ann Arbor. SAMPLE: 286 patients who had smoked within six months of the screening survey were eligible for a smoking-cessation intervention. METHODS: Descriptive statistics and bivariate and multivariate logistic regression were used to determine the independent predictors of smokers' participation in an intervention study. MAIN RESEARCH VARIABLES: Perceived difficulty quitting (as a construct of self-efficacy), health behaviors (i.e., smoking and problem drinking), clinical characteristics (i.e., depression and cancer site and stage), and demographic variables. FINDINGS: Forty-eight percent of those eligible participated. High perceived difficulty quitting was the only statistically significant predictor of participation, whereas problem drinking, lower depressive symptoms, and laryngeal cancer site approached significance. CONCLUSIONS: Special outreach may be needed to reach patients with head and neck cancer who are overly confident in quitting, problem drinkers, and patients with laryngeal cancer. IMPLICATIONS FOR NURSING: Oncology nurses are in an opportune position to assess patients' perceived difficulty quitting smoking and motivate them to enroll in cessation programs, ultimately improving quality of life, reducing risk of recurrence, and increasing survival for this population.
PURPOSE/ OBJECTIVES: To determine the predictors of participation in a smoking-cessation program among patients with head and neck cancer. DESIGN: This cross-sectional study is a substudy of a larger, randomized trial of patients with head and neck cancer that determined the predictors of smokers' participation in a cessation intervention. SETTING: Otolaryngology clinics at three Veterans Affairs medical centers (Ann Arbor, MI, Gainesville, FL, and Dallas, TX), and the University of Michigan Hospital in Ann Arbor. SAMPLE: 286 patients who had smoked within six months of the screening survey were eligible for a smoking-cessation intervention. METHODS: Descriptive statistics and bivariate and multivariate logistic regression were used to determine the independent predictors of smokers' participation in an intervention study. MAIN RESEARCH VARIABLES: Perceived difficulty quitting (as a construct of self-efficacy), health behaviors (i.e., smoking and problem drinking), clinical characteristics (i.e., depression and cancer site and stage), and demographic variables. FINDINGS: Forty-eight percent of those eligible participated. High perceived difficulty quitting was the only statistically significant predictor of participation, whereas problem drinking, lower depressive symptoms, and laryngeal cancer site approached significance. CONCLUSIONS: Special outreach may be needed to reach patients with head and neck cancer who are overly confident in quitting, problem drinkers, and patients with laryngeal cancer. IMPLICATIONS FOR NURSING: Oncology nurses are in an opportune position to assess patients' perceived difficulty quitting smoking and motivate them to enroll in cessation programs, ultimately improving quality of life, reducing risk of recurrence, and increasing survival for this population.
Authors: Sonia A Duffy; David L Ronis; Marcia Valenstein; Michael T Lambert; Karen E Fowler; Lynn Gregory; Carol Bishop; Larry L Myers; Frederic C Blow; Jeffrey E Terrell Journal: Cancer Epidemiol Biomarkers Prev Date: 2006-11 Impact factor: 4.254
Authors: Janet Audrain-McGovern; Chanita Hughes Halbert; Daniel Rodriguez; Leonard H Epstein; Kenneth P Tercyak Journal: Cancer Epidemiol Biomarkers Prev Date: 2007-03-02 Impact factor: 4.254
Authors: Patricia Daza; Ludmila Cofta-Woerpel; Carlos Mazas; Rachel T Fouladi; Paul M Cinciripini; Ellen R Gritz; David W Wetter Journal: Subst Use Misuse Date: 2006 Impact factor: 2.164
Authors: Sonia A Duffy; David L Ronis; Marcia Valenstein; Karen E Fowler; Michael T Lambert; Carol Bishop; Jeffrey E Terrell Journal: Psychosomatics Date: 2007 Mar-Apr Impact factor: 2.386
Authors: Ellen R Gritz; Michelle Cororve Fingeret; Damon J Vidrine; Amy B Lazev; Netri V Mehta; Gregory P Reece Journal: Cancer Date: 2006-01-01 Impact factor: 6.860
Authors: Neal D Freedman; Christian C Abnet; Michael F Leitzmann; Albert R Hollenbeck; Arthur Schatzkin Journal: Cancer Date: 2007-10-01 Impact factor: 6.860
Authors: Allison J Carroll; Anna K Veluz-Wilkins; Sonja Blazekovic; Ravi Kalhan; Frank T Leone; E Paul Wileyto; Robert A Schnoll; Brian Hitsman Journal: Psychooncology Date: 2017-08-04 Impact factor: 3.894
Authors: Alana M Rojewski; Stephen Baldassarri; Nina A Cooperman; Ellen R Gritz; Frank T Leone; Megan E Piper; Benjamin A Toll; Graham W Warren Journal: Nicotine Tob Res Date: 2016-01-17 Impact factor: 4.244
Authors: Margaret L Longacre; John A Ridge; Barbara A Burtness; Thomas J Galloway; Carolyn Y Fang Journal: Oral Oncol Date: 2011-12-09 Impact factor: 5.337
Authors: Graham W Warren; James R Marshall; K Michael Cummings; Benjamin Toll; Ellen R Gritz; Alan Hutson; Seyedeh Dibaj; Roy Herbst; Carolyn Dresler Journal: J Thorac Oncol Date: 2013-05 Impact factor: 15.609
Authors: Graham W Warren; James R Marshall; K Michael Cummings; Benjamin A Toll; Ellen R Gritz; Alan Hutson; Seyedeh Dibaj; Roy Herbst; James L Mulshine; Nasser Hanna; Carolyn A Dresler Journal: J Oncol Pract Date: 2013-07-29 Impact factor: 3.840